175 related articles for article (PubMed ID: 30375048)
1. Hemostasis testing and therapeutic plasma exchange: Results of a practice survey.
Zantek ND; Pagano MB; Rollins-Raval MA; Smith RE; Schmidt AE; Crane JE; Boral LI; Li Y; Svensson AM; Yamada C; Wu Y; Wong ECC
J Clin Apher; 2019 Feb; 34(1):26-32. PubMed ID: 30375048
[TBL] [Abstract][Full Text] [Related]
2. Hemostasis management and therapeutic plasma exchange: Results of a practice survey.
Zantek ND; Boral LI; Li Y; Yamada C; Svensson AM; Crane JE; Smith RE; Pagano MB; Rollins-Raval MA; Schmidt AE; Wong ECC; Wu Y
J Clin Apher; 2018 Oct; 33(5):604-610. PubMed ID: 30207610
[TBL] [Abstract][Full Text] [Related]
3. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
Vatazin AV; Zulkarnaev AB
Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM).
Thölking G; Mesters R; Dittrich R; Pavenstädt H; Kümpers P; Reuter S
PLoS One; 2015; 10(6):e0130402. PubMed ID: 26121484
[TBL] [Abstract][Full Text] [Related]
5. Coagulation status after therapeutic plasma exchange using citrate in kidney transplant recipients.
Yamada C; Pipe SW; Zhao L; Leichtman AB; Samaniego M; Sung RS; Davenport RD
Transfusion; 2016 Dec; 56(12):3073-3080. PubMed ID: 27601087
[TBL] [Abstract][Full Text] [Related]
6. Effect of therapeutic plasma exchange on coagulation parameters in patients on warfarin.
Zantek ND; Morgan S; Zantek PF; Mair DC; Bowman RJ; Aysola A
J Clin Apher; 2014 Apr; 29(2):75-82. PubMed ID: 24000079
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.
Onwuemene OA; Zantek ND; Rollins-Raval MA; Raval JS; Kiss JE; Ipe TS; Kuchibhatla M; Pagano MB; Wong ECC
J Clin Apher; 2019 Oct; 34(5):545-554. PubMed ID: 31116461
[TBL] [Abstract][Full Text] [Related]
8. Changes in hemostasis caused by different replacement fluids and outcome in therapeutic plasma exchange in pediatric patients in a retrospective single center study.
Witt V; Pichler H; Beiglboeck E; Kursten F; Weidner L
Transfus Apher Sci; 2017 Feb; 56(1):59-65. PubMed ID: 28188006
[TBL] [Abstract][Full Text] [Related]
9. Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patients.
Zhang R; Dahl AB; Marchant B; Jackups RR; Karnes HE; Shah P; Dynis M; Thibodeaux SR; Despotis GJ
J Clin Apher; 2020 Jan; 35(1):41-49. PubMed ID: 31713919
[TBL] [Abstract][Full Text] [Related]
10. How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey.
Patriquin CJ; Clark WF; Pavenski K; Arnold DM; Rock G; Foley SR;
J Clin Apher; 2017 Aug; 32(4):246-256. PubMed ID: 27476033
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic effects of therapeutic plasma exchange: A concise review.
Soares Ferreira Júnior A; Hodulik K; Barton KD; Onwuemene OA
J Clin Apher; 2022 Jun; 37(3):292-312. PubMed ID: 35196407
[TBL] [Abstract][Full Text] [Related]
12. Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review.
Hodulik KL; Root AG; Ledbetter LS; Onwuemene OA
Transfusion; 2019 May; 59(5):1870-1879. PubMed ID: 30762882
[TBL] [Abstract][Full Text] [Related]
13. Intensive plasma exchange--effects on haemostasis.
Urbaniak SJ
Prog Clin Biol Res; 1982; 108():191-212. PubMed ID: 7178147
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia: a retrospective case-control study.
Forman KR; Diab Y; Wong EC; Baumgart S; Luban NL; Massaro AN
BMC Pediatr; 2014 Nov; 14():277. PubMed ID: 25367591
[TBL] [Abstract][Full Text] [Related]
16. The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review.
Shunkwiler SM; Pham HP; Wool G; Ipe TS; Fang DC; Biller E; Treml A; Weiss J; Baron BW; Berg M;
J Clin Apher; 2018 Jun; 33(3):371-379. PubMed ID: 29071747
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise.
Mazepa MA; Raval JS; Brecher ME; Park YA
J Clin Apher; 2018 Jun; 33(3):291-296. PubMed ID: 29150875
[TBL] [Abstract][Full Text] [Related]
18. Benefits and challenges of starting a new therapeutic apheresis service in a resource-constrained setting.
Arogundade FA; Sanusi AA; Oguntola SO; Omotoso BA; Abdel-Rahman EM; Akinsola A; Balogun RA
J Clin Apher; 2014 Aug; 29(4):194-8. PubMed ID: 24832211
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic imbalances produced by plasma exchange.
Domen RE; Kennedy MS; Jones LL; Senhauser DA
Transfusion; 1984; 24(4):336-9. PubMed ID: 6464159
[TBL] [Abstract][Full Text] [Related]
20. Management of systemic unfractionated heparin anticoagulation during therapeutic plasma exchange.
Kaplan A; Raut P; Totoe G; Morgan S; Zantek ND
J Clin Apher; 2016 Dec; 31(6):507-515. PubMed ID: 26752590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
